» Articles » PMID: 17496919

MAP Kinases and the Control of Nuclear Events

Overview
Journal Oncogene
Date 2007 May 15
PMID 17496919
Citations 191
Authors
Affiliations
Soon will be listed here.
Abstract

The mitogen-activated protein kinases (MAPKs) are a family of serine/threonine kinases that play an essential role in signal transduction by modulating gene transcription in the nucleus in response to changes in the cellular environment. They include the extracellular signal-regulated protein kinases (ERK1 and ERK2); c-Jun N-terminal kinases (JNK1, JNK2, JNK3); p38s (p38alpha, p38beta, p38gamma, p38delta) and ERK5. The molecular events in which MAPKs function can be separated in discrete and yet interrelated steps: activation of the MAPK by their upstream kinases, changes in the subcellular localization of MAPKs, and recognition, binding and phosphorylation of MAPK downstream targets. The resulting pattern of gene expression will ultimately depend on the integration of the combinatorial signals provided by the temporal activation of each group of MAPKs. This review will focus on how the specificity of signal transmission by MAPKs is achieved by scaffolding molecules and by the presence of structural motifs in MAPKs that are dynamically regulated by phosphorylation and protein-protein interactions. We discuss also how MAPKs recognize and phosphorylate their target nuclear proteins, including transcription factors, co-activators and repressors and chromatin-remodeling molecules, thereby affecting an intricate balance of nuclear regulatory molecules that ultimately control gene expression in response to environmental cues.

Citing Articles

Fas Apoptosis Inhibitory Molecule 2 Inhibits Pathological Cardiac Hypertrophy by Regulating the MAPK Signaling Pathway.

Zhong H, Wu M, Xie H, Chen X, Li J, Duan Z J Am Heart Assoc. 2024; 13(22):e034257.

PMID: 39547961 PMC: 11681402. DOI: 10.1161/JAHA.124.034257.


Ameliorative effects of osthole on acrylamide-induced neurotoxicity in PC12 cells: Role of oxidative stress, apoptosis and ERK pathways.

Kachranlouei L, Hosseinzadeh H, Karimi G, Rajabian F, Mehri S Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39470816 DOI: 10.1007/s00210-024-03560-3.


Exosomal miRNAs: the tumor's trojan horse in selective metastasis.

Bayat M, Nahand J Mol Cancer. 2024; 23(1):167.

PMID: 39164756 PMC: 11334467. DOI: 10.1186/s12943-024-02081-0.


Role of Mitogen-Activated Protein (MAP) Kinase Pathways in Metabolic Diseases.

Ng G, Loh Z, Fann D, Mallilankaraman K, Arumugam T, Hande M Genome Integr. 2024; 15:e20230003.

PMID: 38770527 PMC: 11102075. DOI: 10.14293/genint.14.1.004.


Ginsenoside Rg1 promotes β‑amyloid peptide degradation through inhibition of the ERK/PPARγ phosphorylation pathway in an Alzheimer's disease neuronal model.

Quan Q, Ma X, Li M, Li X, Yuan H Exp Ther Med. 2023; 27(1):31.

PMID: 38125359 PMC: 10731411. DOI: 10.3892/etm.2023.12319.